» Articles » PMID: 18180890

Effect of Jin-3-needling Therapy on Plasma Corticosteroid, Adrenocorticotrophic Hormone and Platelet 5-HT Levels in Patients with Generalized Anxiety Disorder

Overview
Date 2008 Jan 9
PMID 18180890
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To observe the therapeutic efficacy of Jin-3-needling therapy (J3N) on generalized anxiety disorder (GAD) through clinical global impression scale (CGI), and to explore the mechanism by measuring the plasma levels of corticosteroid (CS), adrenocorticotrophic hormone (ACTH), and platelet 5-hydroxytryptamine (5-HT) before and after treatment.

Methods: Eighty-six GAD patients with the diagnosis agreeing with the inclusion criteria were assigned, according to the sequence of visiting time, to three groups. The 29 patients in the Western medicine group were treated mainly with fluoxetine or paroxetine, Alprazolam might be given additionally in severe conditions if necessary; the 29 patients in the needling group received J3N therapy with Sishenzhen, Dingshenzhen, Neiguan (PC6), Shenmen (HT7) and Sanyinjiao (SP6) as the chief acupoints selected; and the 28 patients in the combined treatment group were treated with both drugs and needling in the same way as applied in the above two groups. The therapeutic course for all was 6 weeks. Conditions of patients were evaluated before and after treatment with CGI, and levels of CS, ACTH as well as 5-HT were measured by high performance liquid chromatography-electrochemistry.

Results: By CGI scoring, the scores of severity index and the general index were not different significantly in the three groups, but the efficacy index proved to be the highest in the needling group, the second in the combined trentment group, and the lowest in the drug group. Plasma level of ACTH and platelet content of 5-HT were lowered in all the three groups after treatment, showing statistical significance (P<0.05), but no significant change was found in CS level (P>0.05).

Conclusion: The therapeutic efficacy of J3N in treating GAD is equivalent to, but with the efficacy index significantly higher than, that of conventional treatment. Moreover, when combined with drugs, needling might effectively prevent the side effect of the routinely used Western drugs. The regulatory action of needling on platelet 5-HT and plasma ACTH is probably one of the acting pathways for J3N treatment on GAD.

Citing Articles

Efficacy of acupuncture in ameliorating anxiety in Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis.

Wu Z, Liu C, Chan V, Wu X, Huang F, Guo Z Front Aging Neurosci. 2024; 16:1462851.

PMID: 39588511 PMC: 11586373. DOI: 10.3389/fnagi.2024.1462851.


Acupuncture as Add-on Therapy to SSRIs Can Improve Outcomes of Treatment for Anxious Depression: Subgroup Analysis of the AcuSDep Trial.

Zhao B, Li Z, Shi C, Liu Y, Sun Y, Li B Neuropsychiatr Dis Treat. 2024; 20:1049-1064.

PMID: 38770535 PMC: 11104384. DOI: 10.2147/NDT.S446034.


Efficacy of manual acupuncture versus placebo acupuncture for generalized anxiety disorder (GAD) in perimenopause women: study protocol for a randomized controlled trial.

Liu X, Xie X, Li Y, Li M, Wang Y, Wang N Trials. 2021; 22(1):833.

PMID: 34819129 PMC: 8612005. DOI: 10.1186/s13063-021-05756-x.


A randomized pilot study of electro-acupuncture treatment for hysterosalpingography pain relief and related anxiety.

Bakacak Z, Demirel A, Bakacak M, Urfalioglu A, Yaylali A, Boran O Turk J Obstet Gynecol. 2020; 17(4):253-258.

PMID: 33343971 PMC: 7731605. DOI: 10.4274/tjod.galenos.2020.66592.


Efficacy and safety of acupuncture combined with western medicine for anxiety: A systematic review protocol.

Tan A, Wang M, Liu J, Huang K, Dai D, Li L Medicine (Baltimore). 2020; 99(31):e21445.

PMID: 32756161 PMC: 7402772. DOI: 10.1097/MD.0000000000021445.


References
1.
Gerra G, Zaimovic A, Zambelli U, Timpano M, Reali N, Bernasconi S . Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology. 2000; 42(2):82-92. DOI: 10.1159/000026677. View

2.
Tiller J, Biddle N, Maguire K, Davies B . The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry. 1988; 23(3):261-70. DOI: 10.1016/0006-3223(88)90037-6. View